Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics. Based in the vibrant Boston Seaport area, our mission is to advance the field of immunology with cutting-edge...
For more information visit: https://www.prnewswire.com/news-releases/bambusa-therapeutics-inc-announces-successful-series-seed-funding-to-advance-innovative-bispecific-antibodies-for-immunology–inflammation-302241958.html?tc=eml_cleartime
InPlanet raised an oversubscribed Seed round to increase funding to €5,6M from leading impact, climate and deeptech investors, to become the leading Enhanced Rock Weathering company in the tropics. – Spreading large amounts of rock powder has the potential to...
Espoo, Finland, 9th November 2023 – IQM Quantum Computers (IQM), a global leader in building quantum computers, today unveiled its quantum computing platform, “IQM Radiance”, aiming to pave the way to quantum advantage within the next years with a 150-qubit...
Passau, March 14, 2023 – With Benedikt von Schoeler, AI specialist One Data gains a true deep-tech expert for its advisory board: The tech investor and management expert will accompany the fast-growing software company in an advisory capacity on its growth path and...
Merseburg, February 8, 2023 – Today, LyondellBasell, a global leader in the chemical industry and KIRKBI A/S, the family-owned holding and investment company of the LEGO® brand, announce they have signed an agreement to make an investment in APK, which specializes in...
TOKYO, November 17, 2022 – Astellas Pharma Inc. today announced positive topline results from the Phase 3 SPOTLIGHT clinical trial evaluating the efficacy and safety of zolbetuximab in combination with mFOLFOX6 (a combination regimen that includes oxaliplatin,...